1. Home
  2. FNWD vs EQ Comparison

FNWD vs EQ Comparison

Compare FNWD & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

HOLD

Current Price

$43.26

Market Cap

147.7M

Sector

Finance

ML Signal

HOLD

Logo Equillium Inc.

EQ

Equillium Inc.

HOLD

Current Price

$2.40

Market Cap

151.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
EQ
Founded
1994
2017
Country
United States
United States
Employees
N/A
14
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.7M
151.5M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
FNWD
EQ
Price
$43.26
$2.40
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$37.50
$8.00
AVG Volume (30 Days)
10.5K
497.7K
Earning Date
04-28-2026
05-25-2026
Dividend Yield
1.51%
N/A
EPS Growth
N/A
N/A
EPS
1.00
N/A
Revenue
N/A
$41,095,000.00
Revenue This Year
$17.40
N/A
Revenue Next Year
$5.44
N/A
P/E Ratio
$43.03
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.05
$0.76
52 Week High
$45.90
$3.54

Technical Indicators

Market Signals
Indicator
FNWD
EQ
Relative Strength Index (RSI) 54.11 52.30
Support Level $36.08 $2.36
Resistance Level $45.90 $2.60
Average True Range (ATR) 0.56 0.20
MACD -0.46 0.04
Stochastic Oscillator 14.95 77.12

Price Performance

Historical Comparison
FNWD
EQ

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: